Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Mitie Group delivers 'strong trading momentum' in Q1

(Sharecast News) - Facilities manager Mitie Group said on Tuesday that it had witnessed "strong trading momentum" in Q1, with revenues up double digits in the period. Mitie said revenues grew by 10.1% in the three months ended 30 June to £1.28bn, including 8.0% organic growth driven by net wins and scope increases, project growth and pricing.

The FTSE 250-listed firm delivered contract wins and extensions/renewals with a total contract value of £1.2bn in the quarter, down from a record prior year comparative £2.0bn, including "several notable new key accounts".

Mitie also said it had a record £29.0bn pipeline of bidding opportunities, up 22% over the period, and stated it had made continued progress with margin enhancement initiatives.

Closing net debt of £240.0m was up £41.0m quarter-on-quarter, reflecting capital deployments, a seasonal working capital outflow, and leases. Q126's average daily net debt of £238.0m was a marked increase on Q125's £173.0m average.

Chief executive Phil Bentley said: "In the first quarter of our new fiscal year, we have maintained strong trading momentum, with double-digit revenue growth. Our core facilities management offer grew by 7.3%, as we secured and extended a number of key accounts, whilst facilities transformation - delivered through client projects work - grew by 12.8%, against a strong prior year comparative.

"With today's strong update, we remain on track to deliver our ambitious strategic plan, pivoting Mitie from being the UK leader in facilities management to the leader in technology and project-led facilities transformation."

As of 0810 BST, Mitie shares were up 1.89% at 140.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.